Meiact Use In Pregnancy & Lactation





The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Use In Pregnancy & Lactation
100 mg tablet: This product should be administered to pregnant women or women who may possibly be pregnant, only if the expected therapeutic benefits outweigh the possible risks associated with treatment. [The safety of this product during pregnancy has not been established.]
200 mg tablet: Pregnancy: Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see Pharmacology: Toxicology: Preclinical safety data under Actions). There are no adequate data from the use of cefditoren pivoxil in pregnant women.
Lactation: There is insufficient evidence available on whether cefditoren is present in human milk. Therefore, the administration of MEIACT is not recommended during lactation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in